These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30831428)

  • 41. Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle.
    Apponi LH; Corbett AH; Pavlath GK
    Skelet Muscle; 2013 Oct; 3(1):23. PubMed ID: 24083404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy.
    Fan X; Rouleau GA
    Can J Neurol Sci; 2003 Feb; 30(1):8-14. PubMed ID: 12619777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy.
    Ribot C; Soler C; Chartier A; Al Hayek S; Naït-Saïdi R; Barbezier N; Coux O; Simonelig M
    PLoS Genet; 2022 Jan; 18(1):e1010015. PubMed ID: 35025870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.
    Phillips BL; Banerjee A; Sanchez BJ; Di Marco S; Gallouzi IE; Pavlath GK; Corbett AH
    Nucleic Acids Res; 2018 Sep; 46(15):7643-7661. PubMed ID: 29939290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
    Brais B
    Cytogenet Genome Res; 2003; 100(1-4):252-60. PubMed ID: 14526187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.
    Richard P; Trollet C; Gidaro T; Demay L; Brochier G; Malfatti E; Tom FM; Fardeau M; Lafor P; Romero N; Martin-N ML; Sol G; Ferrer-Monasterio X; Saint-Guily JL; Eymard B
    J Neuromuscul Dis; 2015 Jun; 2(2):175-180. PubMed ID: 27858728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
    Davies JE; Berger Z; Rubinsztein DC
    Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1.
    Tavanez JP; Bengoechea R; Berciano MT; Lafarga M; Carmo-Fonseca M; Enguita FJ
    PLoS One; 2009 Jul; 4(7):e6418. PubMed ID: 19641605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-talk between canonical Wnt signaling and the sirtuin-FoxO longevity pathway to protect against muscular pathology induced by mutant PABPN1 expression in C. elegans.
    Pasco MY; Catoire H; Parker JA; Brais B; Rouleau GA; Néri C
    Neurobiol Dis; 2010 Jun; 38(3):425-33. PubMed ID: 20227501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
    Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
    Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Animal model of oculopharyngeal muscular dystrophy.
    Uyama E; Hino H; Araki K; Takeya M; Uchino M; Yamamura K
    Acta Myol; 2005 Oct; 24(2):84-8. PubMed ID: 16550922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy.
    Abu-Baker A; Parker A; Ramalingam S; Laganiere J; Brais B; Neri C; Dion P; Rouleau G
    Neurology; 2018 Aug; 91(6):e551-e561. PubMed ID: 30006409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oculopharyngeal Muscular Dystrophy and Inherited Retinal Dystrophy in Bukhara Jews Due to Linked Mutations in the PABPN1 and NRL Genes.
    Braverman I; Blumen SC; Newman H; Rizel L; Khayat M; Hanna R; St Guily JL; Tiosano B; Ben-Yosef T
    Genet Test Mol Biomarkers; 2017 Jul; 21(7):450-453. PubMed ID: 28590779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.
    Dion P; Shanmugam V; Gaspar C; Messaed C; Meijer I; Toulouse A; Laganiere J; Roussel J; Rochefort D; Laganiere S; Allen C; Karpati G; Bouchard JP; Brais B; Rouleau GA
    Neurobiol Dis; 2005 Apr; 18(3):528-36. PubMed ID: 15755680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
    Barbezier N; Chartier A; Bidet Y; Buttstedt A; Voisset C; Galons H; Blondel M; Schwarz E; Simonelig M
    EMBO Mol Med; 2011 Jan; 3(1):35-49. PubMed ID: 21204267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo.
    Chartier A; Raz V; Sterrenburg E; Verrips CT; van der Maarel SM; Simonelig M
    Hum Mol Genet; 2009 May; 18(10):1849-59. PubMed ID: 19258344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.